Cargando…
Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis
BACKGROUND: To explore the modulatory effects and mechanism of secretory clusterin (sCLU) on cancer stem cell (CSC) properties in hepatocellular carcinoma (HCC). METHODS: The effects of sCLU repression or overexpression on chemoresistance, migration, invasion, and tumor growth were detected by MTT,...
Autores principales: | Zheng, Wenjie, Yao, Min, Wu, Mengna, Yang, Junling, Yao, Dengfu, Wang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023808/ https://www.ncbi.nlm.nih.gov/pubmed/32059741 http://dx.doi.org/10.1186/s12967-020-02262-7 |
Ejemplares similares
-
Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target
por: Zheng, Wenjie, et al.
Publicado: (2016) -
Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3β/β-catenin Signaling
por: Wang, Cun, et al.
Publicado: (2016) -
MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK‐3β/β‐catenin signalling
por: Shi, Yangfeng, et al.
Publicado: (2021) -
SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
por: Dai, Shuang, et al.
Publicado: (2018) -
TRIB2 Stimulates Cancer Stem-Like Properties through Activating the AKT-GSK3β-β-Catenin Signaling Axis
por: Kim, Dae Kyoung, et al.
Publicado: (2021)